Skip to content
HowShorted

Sally Beauty Holdings, Inc. short interest in 2023

In 2023, Sally Beauty Holdings, Inc.'s disclosed short interest ran from 7.58% of shares outstanding on 13 Jan 2023 to 13.61% on 29 Dec 2023, a change of +6.03 percentage points. The year's high was 13.61% on 29 Dec 2023 and its low 6.51% on 31 May 2023, averaging 9.03% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.02 days on 29 Dec 2023. Full history: Sally Beauty Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Sally Beauty Holdings, Inc. in 2023

2023 in figures

Start of year
7.58% (13 Jan 2023)
End of year
13.61% (29 Dec 2023)
Change
+6.03 pp
High
13.61% (29 Dec 2023)
Low
6.51% (31 May 2023)
Average
9.03%
Highest days to cover
10.02 (29 Dec 2023)
SEC filings marked
8

Every report in 2023

Sally Beauty Holdings, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20237.58%6.11
31 Jan 20238.30%7.38
15 Feb 20238.47%5.7610-Q filed, results (8-K)
28 Feb 20239.01%8.61
15 Mar 20239.10%6.85
31 Mar 20237.98%6.39
14 Apr 20238.44%8.17
28 Apr 20237.18%6.12
15 May 20236.57%4.1610-Q filed, results (8-K)
31 May 20236.51%5.28
15 Jun 20236.84%4.03
30 Jun 20237.14%4.18
14 Jul 20237.45%6.31
31 Jul 20238.15%5.90
15 Aug 20238.33%4.9310-Q filed, results (8-K)
31 Aug 20239.05%6.33
15 Sep 202310.01%5.01
29 Sep 202312.33%4.95
13 Oct 202310.19%3.90
31 Oct 202310.79%5.79
15 Nov 20239.57%4.74results (8-K)
30 Nov 202311.26%6.2210-K filed
15 Dec 202312.76%5.14
29 Dec 202313.61%10.02

See also: Sally Beauty Holdings, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.